This meeting will present current approaches and technologies in drug discovery within oncology and neuroscience research. The programme brings together perspectives on how different preclinical strategies and model systems support drug development from early discovery through IND. Key aspects of antibody–drug conjugate (ADC) development will be covered, including considerations related to efficacy, safety, and resistance. […]

Medicon Valley Alliance and Arithmos would like to welcome you to a Good Morning Meeting 27th of May 2026. The Trial Master File has always been more than a place to store documents. However for too long it has been treated as exactly that. Your records are quietly telling you something about the health of […]

Regulated bioanalysis continues to evolve alongside increasingly complex therapeutic modalities and the need to accelerate drug development without compromising data quality. Recent years have seen a shift toward more streamlined, fit-for-purpose bioanalytical strategies, prompting a re-evaluation of long-standing conventions while remaining firmly grounded in science. This Good Morning Meeting will highlight current hot topics in […]

Patents are challenged during examination, opposition, and invalidity proceedings and are subjected to scrutiny during due diligence. Patent authorities and competitors try to break through the defenses. Licensees use any weakness in the patents to lower the price. Only the good patents survive. Learn from the patent experts of Høiberg how to distinguish good from […]

Patents are challenged during examination, opposition, and invalidity proceedings and are subjected to scrutiny during due diligence. Patent authorities and competitors try to break through the defenses. Licensees use any weakness in the patents to lower the price. Only the good patents survive. Learn from the patent experts of Høiberg how to distinguish good from […]

IPR rules and issues in relation to the Korean market  is patenting different in Korea, compared to Europe and USA? Yes  there are differences in legislation and practices in addition to cultural differences, which together may lead to a different outcome in the patent application process in Korea compared to Europe or America. […]